Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydroxyurea to inhibit human immunodeficiency virus-1 replication.

F Romanelli1, C Pomeroy, K M Smith

  • 1Division of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington 40536, USA.

Pharmacotherapy
|February 25, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-Domain Extreme-Ultraviolet Diffuse Scattering Spectroscopy of Nanoscale Surface Phonons.

Physical review letters·2026
Same author

Trend of sexually transmitted infections during the Covid-19 age. What was the impact of the pandemic and the social distancing measures?

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Monitoring testosterone replacement therapy with transdermal gel: when and how?

Journal of endocrinological investigation·2019
Same author

Gender in Endocrine Diseases: Role of Sex Gonadal Hormones.

International journal of endocrinology·2018
Same author

Clinical presentation and management of patients with primary hyperparathyroidism in Italy.

Journal of endocrinological investigation·2018
Same author

Supra-physiological rhGH administration induces gender-related differences in the hypothalamus-pituitary-thyroid (HPT) axis in healthy individuals.

Journal of endocrinological investigation·2016

Hydroxyurea shows potential as an effective component in human immunodeficiency virus (HIV) treatment regimens. Further research into hydroxyurea-based drug combinations is warranted to explore alternative HIV therapies.

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • Human immunodeficiency virus (HIV) treatment faces challenges with current standard regimens.
  • Standard HIV therapies involve nucleoside reverse transcriptase inhibitors and protease inhibitors.
  • These regimens necessitate strict adherence, present adverse effects, and incur high costs.

Purpose of the Study:

  • To critically review the existing literature on hydroxyurea's efficacy against HIV.
  • To examine the utility of hydroxyurea-based drug combinations as alternative HIV treatments.

Main Methods:

  • A comprehensive literature review was conducted.
  • Studies examining hydroxyurea in combination therapy for HIV were analyzed.

Related Experiment Videos

Main Results:

  • Hydroxyurea, a ribonucleotide reductase inhibitor, demonstrates potential therapeutic value.
  • The review assesses the role of hydroxyurea in novel HIV drug combinations.

Conclusions:

  • Hydroxyurea presents a promising option for developing alternative HIV treatment strategies.
  • Exploring hydroxyurea-based combinations is crucial for advancing HIV therapy options.